Norihiko Shiraishi

Company: NANO MRNA Co., Ltd.

Job title: Executive Officer, Chief Scientific Officer & mRNA IPG Unit Head

Bio:

Nori Shiraishi leads NANO MRNA on research and development of mRNA therapeutics, focusing on to establish rich pipeline through internal research and external collaborations with academia, venture companies and pharmaceutical companies. Prior to NANO MRNA, Nori served as senior management of corporate planning in Kyowa Kirin Co., Ltd. He served as global clinical project lead for multiple drugs, low molecular weight compounds, antibodies, and biologics, in oncology, hematology and nephrology area. His research background spans from microbiology, bioinformatics, and molecular biology.

Seminars:

Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS for ASO – New Data 5:00 pm

Presenting a novel drug delivery system for antisense oligonucleotides Achieving success in non-clinical experiments Showcasing early clinical resultsRead more

day: Day Two